Sun Pharmaceutical Industries announced a further update to the IT security incident. The Company promptly took steps to contain and remediate the impact of the IT security incident, including employing containment and eradication protocols to mitigate the threat and additional measures to ensure the integrity of its systems infrastructure and data. These measures are underway as the Company utilizes global cyber security experts and enhanced security measures to address and mitigate the impact of the incident. A ransomware group has claimed responsibility for this incident. The Company currently believes that the incident's effect on its IT systems includes a breach of certain file systems and the theft of certain company data and personal data. 'As part of the containment measures, we proactively isolated our network and initiated the recovery process. As a result of these measures, Company's business operations have been impacted. Consequently, revenues are expected to be reduced in some of our businesses. The Company would incur expenses in connection with the incident and the remediation. The Company is currently unable to determine other potential adverse impacts of the incident, including but not limited to additional information security incidents, increased costs to maintain insurance coverage, the diversion of management and employee time or the possibility of litigation', said the company.